JO
PRAH

John Overdeck’s PRA Health Sciences, Inc. PRAH Stock Holding History

John Overdeck’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-525,778
Closed -$86.9M – 4946
2021
Q2 		$86.9M Buy
525,778
+495,435
+1,633% +$82.7M 0.2% 118
2021
Q1 		$4.65M Buy
+30,343
New +$4.12M 0.01% 1096
2017
Q4 		– Sell
-123,229
Closed -$9.39M – 3556
2017
Q3 		$9.39M Sell
123,229
-19,200
-13% -$1.45M 0.03% 543
2017
Q2 		$10.7M Sell
142,429
-299,649
-68% -$20.8M 0.04% 498
2017
Q1 		$28.8M Buy
442,078
+317,619
+255% +$18.7M 0.1% 277
2016
Q4 		$6.86M Sell
124,459
-143,902
-54% -$7.9M 0.03% 692
2016
Q3 		$15.2M Buy
+268,361
New +$13.2M 0.06% 400
2016
Q2 		– Sell
-45,958
Closed -$1.97M – 3366
2016
Q1 		$1.97M Buy
+45,958
New +$1.94M 0.01% 1194
2015
Q3 		– Sell
-67,232
Closed -$2.44M – 2898
2015
Q2 		$2.44M Buy
+67,232
New +$2.13M 0.01% 1082

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

John Overdeck's PRAH Position: Q3 2021 in Review

John Overdeck sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 525,778 shares — an estimated $86.9M sold.

John Overdeck first reported a position in PRAH in Q2 2015 and held it in 9 quarters. The position peaked at $86.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • John Overdeck reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • John Overdeck sold 525,778 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $86.9M.
  • John Overdeck first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 9 quarters.
  • John Overdeck's PRA Health Sciences, Inc. position peaked at $86.9M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.